Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- ResearchBible
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Proquest Summons
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- MIAR
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.
Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 56 | 30 | 30 | 13 | 4 | 7 | 15 | 13 | 20 | 25 | 12 | 35 | 13 | 2 |
Research, Review articles and Editorials |
0 | 6 | 2 | 4 | 1 | 1 | 6 | 14 | 12 | 17 | 25 | 12 | 34 | 7 | 2 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
30 | 50 | 28 | 8 | 2 | 0 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 102 | 83 | 47 | 82 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
35 | 55 | 58 | 71 | 61 | 49 | 63 | 48 | 72 | 63 | 23 | 8 | 6 | 0 | 0 |
| Journal total citations count | 613 |
| Journal impact factor | 2.31 |
| Journal 5 years impact factor | 3.74 |
| Journal cite score | 4.86 |
| Journal h-index | 12 |
Important citations
Estimating potency in high-throughput screening experiments by maximizing the rate of change in weighted shannon entropy
Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics
Quantitative high-throughput screening data analysis: challenges and recent advances
Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model
Uncertainty quantification in ToxCast high throughput screening
Dose-dependent intracellular reactive oxygen and nitrogen species (ROS/RNS) production from particulate matter exposure: comparison to oxidative potential and chemical composition
An introduction to terminology and methodology of chemical synergy—perspectives from across disciplines
Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service
Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service
Report of the 3rd summit of translational research in health disparities and the 3rd multidisciplinary conference in clinical research
FRANC: a unified framework for multi-way local ancestry deconvolution with high density SNP data
Distribution and Frequencies of Medically Relevant Mutations in the Puerto Rican Population
??????????——2013 ???????????????
Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population
Population heterogeneity and genomic admixture: relevance for global pharmacogenetics
Demographics, clinical characteristics, IFNL3-and IFNL4-polymorphisms in a cohort of hepatitis C patients from Puerto Rico
Association of Native American ancestry and common variants in ACE, ADIPOR2, MTNR1B, GCK, TCF7L2 and FTO genes with glycemic traits in Colombian population
Admixture and ethno-specific alleles: missing links for global pharmacogenomics
Why admixture matters in genetically-guided therapy: missed targets in the COAG and EU-PACT trials
Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans